A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months
PHASE3
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Safety and Immunogenicity of GlaxoSmithKline Biologicals Meningococcal Group B Vaccine When Administered Concomitantly With GlaxoSmithKline Biologicals MenACWY Conjugate Vaccine to Healthy Infants
PHASE3
The purpose of this trial is to evaluate the immunogenicity, the safety and...
Open Randomized Trial Evaluating Four Anti-pneumococcal Vaccine Strategies With Fractionated Doses of Non Conjugate Polysaccharide Vaccine to Prevent Hyporesponse in Healthy Volunteers
PHASE2
Immune response analysis after the combination of PCV13 and PPV23 will lead...